Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Identification of molecular determinants in osteosarcoma using comparative oncogenomics

FY 2008-09

Summary
Osteosarcoma (OS) is the second highest cause of cancer related death in the pediatric age group. While multimodal therapy has significantly improved the prognosis for these patients, long term survival rates remain at ~65%. In OS, as in many cancers, it has been observed that tumor cells gain and lose regions of their DNA, resulting in alterations to the activity of the resident genes. A region of chromosome 6, at 6p21, has been often seen to undergo an increase in DNA copies in OS and many other cancers, indicating that a gene residing within it may be commonly involved in tumor development. Using a mouse model that develops OS, it is my goal to using genome scanning methods to pinpoint a candidate OS gene for 6p21. Combining mouse OS and human cancer data, derived from published studies, a set of genes will be identified. Further, this set of genes will be experimentally tested for their ability to transform normal human bone cells into cancer cells. The identification of a OS gene for 6p21 could represent a valuable drug target, which may be relevant beyond cancers of the bone.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184503
Name
Molyneux Sam D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identification of molecular determinants in osteosarcoma using comparative oncogenomics
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer; Comparative Genomic Hybridization; Gene Expression Analysis; Genomics; Microarray; Molecular Biology; Mouse Models; Osteosarcoma
Abstract
Osteosarcoma (OS) is the second highest cause of cancer related death in the pediatric age group. While multimodal therapy has significantly improved the prognosis for these patients, long term survival rates remain at ~65%. In OS, as in many cancers, it has been observed that tumor cells gain and lose regions of their DNA, resulting in alterations to the activity of the resident genes. A region of chromosome 6, at 6p21, has been often seen to undergo an increase in DNA copies in OS and many other cancers, indicating that a gene residing within it may be commonly involved in tumor development. Using a mouse model that develops OS, it is my goal to using genome scanning methods to pinpoint a candidate OS gene for 6p21. Combining mouse OS and human cancer data, derived from published studies, a set of genes will be identified. Further, this set of genes will be experimentally tested for their ability to transform normal human bone cells into cancer cells. The identification of a OS gene for 6p21 could represent a valuable drug target, which may be relevant beyond cancers of the bone.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Molyneux, Sam D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~